anti-PSMA/anti-CD38 synthetic antibody mimic SyAMs (Kleo Pharmaceuticals/PeptiDream)

N/A

Report date: 2025/01/26 19:25:30

Base Information

Drug Nameanti-PSMA/anti-CD38 synthetic antibody mimic SyAMs (Kleo Pharmaceuticals/PeptiDream)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionLymphocyte differentiation antigen CD38 modulatorsProstate-Specific Membrane Antigen modulators
TargetsProstate-Specific Membrane AntigenLymphocyte differentiation antigen CD38
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKleo Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream IncKleo Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A